Melanoma Clinical Trials in Georgia

Showing 121-140 of 147 trials

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

NCT01835184

This phase I trial studies the side effects and best dose of cabozantinib-s-malate when given together with vemurafenib in treating patients with solid tumors or melanoma that is metastatic or that cannot be removed by surgery. Cabozantinib-s-malate and vemurafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+3 more

National Cancer Institute (NCI)5 participantsStarted May 2013

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Richmond, Virginia, United States

COMPLETEDPHASE1/PHASE265 miles

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

NCT00084214

This study is designed to assess the efficacy of a weekly treatment regimen of STA-4783 and paclitaxel in comparison to paclitaxel alone on tumor response in metastatic melanoma patients.

Melanoma

Synta Pharmaceuticals Corp.103 participantsStarted May 2004

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • San Diego, California, United States +25 more locations

PreviousPage 7 of 8Next

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Melanoma Trials in Other Cities

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

A Study of Volociximab in Metastatic Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Study of CP-675,206 in Refractory Melanoma

CP-675,206 In Patients With Advanced Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

SciBase International Melanoma Pivotal Study

Other Conditions in Georgia